Search for Clinical Trial Results

Sponsored By

Angioid Streaks - 9 Studies Found

Status Study
Withdrawn Study Name: Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks
Condition: Angioid Streaks
Date: 2009-11-17
Interventions: Drug: ranibizumab 0.5 mg dose of ranibizumab. Treatment will be given at baseline, month 1, and month 2,
Withdrawn Study Name: Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).
Condition: Choroidal Neovascularization in Angioid Streaks
Date: 2015-10-07
Interventions: Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o
Withdrawn Study Name: Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks
Condition:
  • Angioid Streaks
  • Choroidal Neovascularization

Date: 2006-06-30
Interventions: Drug: Intravitreal Bevacizumab
Completed Study Name: Intravitreal Bevacizumab in Agioid Streaks
Condition:
  • Angioid Streaks
  • Choroidal Neovascularization

Date: 2006-11-30
Interventions:
  • Drug: intravitreal injection 1
Withdrawn Study Name: Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Condition:
  • Choroidal Neovascularization
  • Myopia
  • Punctate Inner Choroid
    Date: 2010-10-29
    Interventions:
    • Drug: Bevacizumab (Avastin; Genentech, Inc.)

Completed Study Name: Evolution of Visual Impairment During Pseudoxanthoma Elasticum
Condition: Pseudoxanthoma Elasticum
Date: 2007-11-06
Recruiting Study Name: Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
Condition: Pseudoxanthoma Elasticum
Date: 2015-08-21
Interventions: Drug: Aflibercept Intravitreal injection Other Name:
Completed Study Name: Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)
Condition: Choroidal Neovascularization
Date: 2007-08-01
Interventions: Drug: Intravitreal injection ranibizumab Monthly intravitreal injection of 0.5mg ranibizumab in one eye
Completed Study Name: Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
Condition: Choroidal Neovascularization
Date: 2006-08-30
Interventions: Drug: bevacizumab